NCT00918138 - Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg | Biotech Hunter

Enrollment

219

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

Type 2 Diabetes

Interventions

DRUG

Saxagliptin

Tablets, Oral, 5 mg, once daily, 4 weeks

DRUG

Metformin XR

Tablets, Oral, 1500 mg, once daily, 4 weeks

DRUG

Placebo matching Metformin XR

Tablets, Oral, 0 mg, once daily, 4 weeks

DRUG

Metformin XR

Tablets, Oral, 500 mg, once daily, 4 weeks

DRUG

Placebo matching Saxagliptin

Tablets, Oral, 0 mg, once daily, 4 weeks

Trial Locations (21)

1425

Local Institution, Buenos Aires

1429

Local Institution, Capital Federal

10019

Clinilabs, Inc., New York

13100

Local Institution, Safed

30513

River Birch Research Alliance, Llc, Blue Ridge

33012

Palm Springs Research Institute, Hialeah

33134

Clinical Research Of South Florida, Coral Gables

33161

Healthcare Clinical Data, Inc., North Miami

34000

Local Institution, Durango

34075

Local Institution, Durango

44281

Local Institution, Kfar Saba

45212

Medpace Clinical Pharmacology Unit, Cincinnati

49007

Jasper Clinic, Inc., Kalamazoo

58100

Local Institution, Holon

64460

Local Institution, Monterrey

78229

Clinical Trials Of Texas Inc., San Antonio

84088

Advanced Clinical Research, West Jordan

84101

Local Institution, Beersheba

85013

Dedicated Phase I, Inc., Phoenix

92373

Pacific Sleep Medicine Services (Avastra Clinical Trials), Redlands

92780

Orange County Research Center, Tustin